Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-25
1998-01-13
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514616, 546168, 549468, 564 51, 564 74, 564 86, 564152, 564153, 564154, 564158, 564159, A61K 31165, A61K 3147, C07C23318, C07C21548
Patent
active
057080046
ABSTRACT:
Hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4749781 (1988-06-01), Gordon
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5132400 (1992-07-01), Gammill et al.
patent: 5151438 (1992-09-01), Sham et al.
patent: 5157041 (1992-10-01), Handa et al.
Roberts et al, Science, 248, 358 (1990).
Erickson et al, Science, 249:527-533 (1990).
Krohn et al, J.Med.Chem., 34, 3340 (1991).
Drugs of the Future, 1991, 16(3), 210-212.
Meek et al, Nature, 343:90-92, (1990).
McQuade et al, "A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation", Science, 274, 454 (1990).
Pept. Struct. Func. Proc. Am. Pept. Sym. 8th ed. by V.J. Hunby and D.H. Rich, pp. 511-520 (1983).
Rosenberg et al, J. Med. Chem., 30, 1224-1228 (1987).
Fittkau, J. Prakt. Chem. 315, 1037-1044 (1973).
Plattner et al, J. Med. Chem., 31, 2277-88 (1988).
Bolis et al, J. Med. Chem., 30, 1729-37 (1987).
Denkewalter et al, "Progress in Drug Research", 10, 510-12 (1966).
A. Burger, Med. Chem., 2nd Ed., 565-601 (1960).
Haber et al, J. Cardiovasc. Pharmacol, 10, 7, 54-57 (1987).
Reed Kathryn L.
Talley John J.
Dentz Bernard
Monsanto Company
LandOfFree
Retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retroviral protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326560